- Association between teriparatide adherence and healthcare utilization and costs in real-world US kyphoplasty/vertebroplasty patientsY Zhao
Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Osteoporos Int 24:2525-33. 2013..Among KV patients newly initiating teriparatide, significantly increased pharmacy costs associated with high teriparatide adherence were offset by significantly lower inpatient utilization and medical costs...
- Clinical and economic characteristics of hip fracture patients with and without muscle atrophy/weakness in the United StatesYang Zhao
Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936 1080, USA
Arch Osteoporos 8:127. 2013..This retrospective analysis of hip fracture patients with and without muscle atrophy/weakness (MAW) revealed that those with MAW had significantly higher healthcare utilization and costs compared with hip fracture patients without MAW...